Search

everythinglearnresearchcommunity

for

Search:↓

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

ILC1-like cells can cause alopecia areata by themselves.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Blocking interferon-gamma might help treat various autoimmune diseases.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

IL-18 signaling helps mature Tregs move into the thymus.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

IL-18 signaling helps mature Tregs move into the thymus.

Tislelizumab can cause cutaneous lupus erythematosus.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Calancardin B may help reduce inflammation in immune cells.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

B cells can both help and hinder the body's defense against melanoma.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.